36Kr learned that the three major A-share indices opened lower collectively, with the Shanghai Composite Index down 0.3%, the Shenzhen Component Index down 0.14%, and the ChiNext Index down 0.2%; pharmaceutical stocks surged significantly, with weight loss drugs and Alzheimer's direction leading the gains, JinKai Biotechnology rising over 10%, SC Pharmaceuticals rising over 9%, and Huadong Medicine rising over 4%; the precious metals and semiconductor sectors saw significant declines, with SiRuPu down over 3%, Shandong Gold and Zhongjin Gold down over 1%. The major asset restructuring was approved, and RoboTechnik opened up 9.38%
